Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Definitions of the phenotypic manifestations of sickle cell disease.
Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C, Johnson CS, Rogers ZR, Smith-Whitley K, Wang WC, Telen MJ; Investigators, Comprehensive Sickle Cell Centers. Ballas SK, et al. Am J Hematol. 2010 Jan;85(1):6-13. doi: 10.1002/ajh.21550. Am J Hematol. 2010. PMID: 19902523 Free PMC article.
Leg ulcers in sickle cell disease.
Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK. Minniti CP, et al. Among authors: ballas sk. Am J Hematol. 2010 Oct;85(10):831-3. doi: 10.1002/ajh.21838. Am J Hematol. 2010. PMID: 20872960 Free PMC article.
The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients.
Smith WR, Ballas SK, McCarthy WF, Bauserman RL, Swerdlow PS, Steinberg MH, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Smith WR, et al. Among authors: ballas sk. Pain Med. 2011 May;12(5):697-705. doi: 10.1111/j.1526-4637.2011.01096.x. Epub 2011 Apr 11. Pain Med. 2011. PMID: 21481164 Free PMC article. Clinical Trial.
Review/overview of pain in sickle cell disease.
Ballas SK, Darbari DS. Ballas SK, et al. Complement Ther Med. 2020 Mar;49:102327. doi: 10.1016/j.ctim.2020.102327. Epub 2020 Feb 3. Complement Ther Med. 2020. PMID: 32147066 Review.
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, Ataga K, Swerdlow P, Kutlar A, DeCastro L, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up. Steinberg MH, et al. Among authors: ballas sk. Am J Hematol. 2010 Jun;85(6):403-8. doi: 10.1002/ajh.21699. Am J Hematol. 2010. PMID: 20513116 Free PMC article. Clinical Trial.
338 results